|
|
Volumn 27, Issue 4, 1995, Pages 301-305
|
|
Epirubicin and medroxyprogesterone acetate versus estramustine phosphate in hormone-resistant prostatic cancer: A prospective randomized study
a
a
Karmsjukhuset
*
(Sweden)
|
|
Author keywords
Epirubicin; Estramustine phosphate; Medroxyprogesterone; Prostatic cancer, hormone resistant; Randomized study
|
|
Indexed keywords
EPIRUBICIN;
ESTRAMUSTINE PHOSPHATE;
MEDROXYPROGESTERONE ACETATE;
AGED;
ALOPECIA;
ARTICLE;
BONE METASTASIS;
BONE PAIN;
CANCER MORTALITY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG RESISTANCE;
ERYTHROCYTE SEDIMENTATION RATE;
GASTROINTESTINAL SYMPTOM;
HEART FAILURE;
HORMONE RESISTANCE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
MALE;
NAUSEA;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
PROSTATE CANCER;
RANDOMIZED CONTROLLED TRIAL;
VOMITING;
|
|
EID: 0029062830
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000475185 Document Type: Article |
|
Times cited : (8)
|
|
References (0)
|
